Stub

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon unless new evidence comes forward. This page is primarily to drive the Ontology.


Abiraterone & Enzalutamide

back to top

Regimen

Hormonotherapy

Bortezomib & Bevacizumab

back to top

Regimen

Targeted therapy

Bortezomib & Siltuximab

back to top

Regimen

Targeted therapy

Carboplatin & Epirubicin

back to top

Regimen

Chemotherapy

Carboplatin & Topotecan

back to top

Regimen

Chemotherapy

CE & Ipilimumab

back to top

CE & Ipilimumab: Carboplatin, Etoposide, Ipilimumab

Regimen

Chemotherapy

Immunotherapy

CE & Thalidomide

back to top

CE & Thalidomide: Carboplatin, Etoposide, Thalidomide

Regimen

Chemotherapy

Targeted therapy

Docetaxel & Pertuzumab

back to top

Regimen

Chemotherapy

Targeted therapy

Encorafenib monotherapy

back to top

Regimen

Targeted therapy

EP & Ipilimumab

back to top

EP & Ipilimumab: Etoposide, Platinol (Cisplatin), Ipilimumab

Regimen

Chemotherapy

Immunotherapy

EP, Tamoxifen, RT

back to top

EP, GM-CSF, RT: Etoposide, Platinol (Cisplatin), Tamoxifen, Radiation Therapy

Regimen

Chemotherapy

Hormonotherapy

Radiotherapy

FEC & HP

back to top

FEC & HP: Fluorouracil, Epirubicin, Cyclophosphamide, Herceptin (Trastuzumab), Pertuzumab

Regimen

Chemotherapy

Targeted therapy

FULV & Trimetrexate

back to top

FULV & Trimetrexate: 5-FU & LeucoVorin (Folinic acid), Trimetrexate

Regimen

Chemotherapy

Ixabepilone & Bevacizumab

back to top

Regimen

Chemotherapy

Targeted therapy

MFL

back to top

MFL: Methyl-lomustine (MeCCNU), 5-FU & LeucoVorin (Folinic acid)

Regimen

Chemotherapy

Mitoxantrone & Hydrocortisone

back to top

Regimen

Chemotherapy

Hormonotherapy

PD & Pembrolizumab

back to top

PD & Pembrolizumab: Pomalidomide, Dexamethasone, Pembrolizumab

Regimen

Targeted therapy

Immunotherapy

Pixantrone & Rituximab

back to top

Regimen

Chemotherapy

Targeted therapy

TCHL (Taxotere)

back to top

TCHL: Taxotere (Docetaxel), Carboplatin, Herceptin (Trastuzumab), Lapatinib

Regimen

Chemotherapy

Targeted therapy

TEC

back to top

TEC: Taxol (Paclitaxel), Epirubicin, Carboplatin

Regimen

Chemotherapy

TG+Bev

back to top

TG+Bev: Taxotere (Docetaxel), Gemcitabine, Bevacizumab

Regimen

Chemotherapy

Targeted therapy

TL (Taxotere)

back to top

TL: Taxotere (Docetaxel) & Lapatinib

Regimen

Chemotherapy

Targeted therapy

TX+Bev

back to top

TX+Bev: Taxotere (Docetaxel), Xeloda (Capecitabine), Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Vinorelbine & Hydrocortisone

back to top

Regimen

Chemotherapy

Hormonotherapy